Two Sigma Investments LP Has $307,000 Stock Holdings in Simulations Plus, Inc. (NASDAQ:SLP)

Two Sigma Investments LP cut its stake in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 61.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,006 shares of the technology company's stock after selling 17,811 shares during the quarter. Two Sigma Investments LP owned about 0.05% of Simulations Plus worth $307,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in SLP. Jones Financial Companies Lllp grew its stake in Simulations Plus by 53.6% in the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock worth $34,000 after purchasing an additional 427 shares in the last quarter. Johnson Financial Group Inc. acquired a new position in Simulations Plus in the fourth quarter valued at approximately $39,000. Tower Research Capital LLC TRC boosted its stake in Simulations Plus by 42.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock valued at $72,000 after acquiring an additional 764 shares during the period. AlphaQuest LLC boosted its stake in Simulations Plus by 502.9% in the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock valued at $75,000 after acquiring an additional 2,243 shares during the period. Finally, KLP Kapitalforvaltning AS acquired a new position in Simulations Plus in the fourth quarter valued at approximately $86,000. 78.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the company's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $33.51, for a total transaction of $670,200.00. Following the completion of the sale, the director now directly owns 3,344,157 shares in the company, valued at $112,062,701.07. This represents a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 19.40% of the company's stock.

Analyst Upgrades and Downgrades

SLP has been the subject of several analyst reports. William Blair reiterated an "outperform" rating on shares of Simulations Plus in a research report on Tuesday, June 3rd. Wall Street Zen raised Simulations Plus from a "sell" rating to a "hold" rating in a report on Monday, April 28th. KeyCorp upped their price target on Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, April 16th. Finally, Craig Hallum dropped their price target on Simulations Plus from $45.00 to $36.00 and set a "buy" rating on the stock in a report on Friday. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $41.25.

Simulations Plus Stock Performance

Shares of NASDAQ SLP traded down $0.98 during mid-day trading on Friday, reaching $19.07. The company had a trading volume of 946,113 shares, compared to its average volume of 239,970. Simulations Plus, Inc. has a twelve month low of $18.66 and a twelve month high of $49.71. The stock has a market capitalization of $383.52 million, a PE ratio of 47.68 and a beta of 0.97. The stock's 50 day moving average is $30.64 and its 200-day moving average is $30.14.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. The firm had revenue of $22.43 million during the quarter, compared to analysts' expectations of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. Simulations Plus's revenue for the quarter was up 22.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.20 earnings per share. On average, sell-side analysts anticipate that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.